Health Catalyst, Inc.

Symbol: HCAT

NASDAQ

6.67

USD

Market price today

  • -3.2448

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 393.75M

    MRK Cap

  • 0.00%

    DIV Yield

Health Catalyst, Inc. (HCAT) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.42%

Operating Profit Margin

-0.39%

Net Profit Margin

-0.40%

Return on Assets

-0.17%

Return on Equity

-0.31%

Return on Capital Employed

-0.19%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO:Mr. Daniel D. Burton
Full-time employees:1300
City:South Jordan
Address:10897 South River Front Parkway
IPO:2019-07-25
CIK:0001636422

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

General Outlook

When we look at how much money they make before expenses, they keep 0.418% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.391%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.399%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.168% return, is a testament to Health Catalyst, Inc.'s adeptness in optimizing resource deployment. Health Catalyst, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.306%. Furthermore, the proficiency of Health Catalyst, Inc. in capital utilization is underscored by a remarkable -0.189% return on capital employed.

Stock Prices

Health Catalyst, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6.46, while its low point bottomed out at $6.17. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Health Catalyst, Inc.'s stock market.

Liquidity Ratios

Analyzing HCAT liquidity ratios reveals its financial health of the firm. The current ratio of 439.38% gauges short-term asset coverage for liabilities. The quick ratio (425.59%) assesses immediate liquidity, while the cash ratio (119.37%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio439.38%
Quick Ratio425.59%
Cash Ratio119.37%

Profitability Ratios

HCAT profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -39.80% underscores its earnings before tax deductions. The effective tax rate stands at -0.30%, revealing its tax efficiency. The net income per EBT, 100.30%, and the EBT per EBIT, 101.92%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -39.05%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-39.80%
Effective Tax Rate-0.30%
Net Income per EBT100.30%
EBT per EBIT101.92%
EBIT per Revenue-39.05%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.39, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 483.64% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding426
Operating Cycle75.47
Days of Payables Outstanding14
Cash Conversion Cycle61
Receivables Turnover4.84
Payables Turnover25.96
Inventory Turnover172369000.00
Fixed Asset Turnover7.47
Asset Turnover0.42

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.58, and free cash flow per share, -0.82, depict cash generation on a per-share basis. The cash per share value, 5.53, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.11, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.58
Free Cash Flow per Share-0.82
Cash per Share5.53
Operating Cash Flow Sales Ratio-0.11
Free Cash Flow to Operating Cash Flow Ratio1.43
Cash Flow Coverage Ratio-0.14
Short Term Coverage Ratio-9.85
Capital Expenditure Coverage Ratio-2.31
Dividend Paid and Capex Coverage Ratio-2.31

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 32.97%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.63, we discern the balance between debt and equity financing. The long-term debt to capitalization, 38.33%, and total debt to capitalization, 38.67%, ratios shed light on its capital structure. An interest coverage of -13.90 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio32.97%
Debt Equity Ratio0.63
Long Term Debt to Capitalization38.33%
Total Debt to Capitalization38.67%
Interest Coverage-13.90
Cash Flow to Debt Ratio-0.14
Company Equity Multiplier1.91

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 5.25, provides a glimpse into top-line earnings distributed across each share. Net income per share, -2.09, reflects the portion of profit attributed to each share. The book value per share, 6.50, represents the net asset value distributed per share, while the tangible book value per share, 1.82, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share5.25
Net Income Per Share-2.09
Book Value Per Share6.50
Tangible Book Value Per Share1.82
Shareholders Equity Per Share6.50
Interest Debt Per Share4.23
Capex Per Share-0.25

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 7.13%, indicates top-line expansion, while the gross profit growth, -30.47%, reveals profitability trends. EBIT growth, 38.75%, and operating income growth, 38.75%, offer insights into operational profitability progression. The net income growth, 14.01%, showcases bottom-line expansion, and the EPS growth, 18.36%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth7.13%
Gross Profit Growth-30.47%
EBIT Growth38.75%
Operating Income Growth38.75%
Net Income Growth14.01%
EPS Growth18.36%
EPS Diluted Growth17.72%
Weighted Average Shares Growth5.02%
Weighted Average Shares Diluted Growth4.32%
Operating Cash Flow Growth6.21%
Free Cash Flow Growth10.05%
10-Year Revenue Growth per Share99.30%
5-Year Revenue Growth per Share29.38%
3-Year Revenue Growth per Share9.83%
10-Year Operating CF Growth per Share55.79%
5-Year Operating CF Growth per Share59.60%
3-Year Operating CF Growth per Share11.34%
10-Year Net Income Growth per Share-23.62%
5-Year Net Income Growth per Share6.19%
3-Year Net Income Growth per Share28.01%
10-Year Shareholders Equity Growth per Share169.60%
5-Year Shareholders Equity Growth per Share148.18%
3-Year Shareholders Equity Growth per Share-6.86%
Receivables Growth27.56%
Asset Growth-6.71%
Book Value per Share Growth-17.79%
Debt Growth0.44%
R&D Expense Growth-9.48%
SGA Expenses Growth-26.38%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 665,226,356.22, captures the company's total value, considering both debt and equity. Income quality, 0.28, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.26, gauges operational efficiency, while the research and development to revenue, 23.15%, highlights investment in innovation. The ratio of intangibles to total assets, 37.62%, indicates the value of non-physical assets, and capex to operating cash flow, 43.26%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value665,226,356.22
Income Quality0.28
Sales General and Administrative to Revenue0.26
Research and Development to Revenue23.15%
Intangibles to Total Assets37.62%
Capex to Operating Cash Flow43.26%
Capex to Revenue-4.84%
Capex to Depreciation-31.65%
Stock-Based Compensation to Revenue18.84%
Graham Number17.51
Return on Tangible Assets-26.99%
Graham Net Net0.51
Working Capital302,163,000
Tangible Asset Value102,883,000
Net Current Asset Value56,302,000
Invested Capital1
Average Receivables54,580,000
Average Payables5,532,500
Average Inventory0.5
Days Sales Outstanding75
Days Payables Outstanding12
ROIC-14.38%
ROE-0.32%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.04, and the price to book ratio, 1.04, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.33, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -8.31, and price to operating cash flows, -11.59, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.04
Price to Book Ratio1.04
Price to Sales Ratio1.33
Price Cash Flow Ratio-11.59
Enterprise Value Multiple-3.46
Price Fair Value1.04
Price to Operating Cash Flow Ratio-11.59
Price to Free Cash Flows Ratio-8.31
Price to Tangible Book Ratio1.42
Enterprise Value to Sales2.25
Enterprise Value Over EBITDA-16.41
EV to Operating Cash Flow-20.11
Earnings Yield-22.61%
Free Cash Flow Yield-9.07%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Health Catalyst, Inc. (HCAT) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -3.245 in 2024.

What is the ticker symbol of Health Catalyst, Inc. stock?

The ticker symbol of Health Catalyst, Inc. stock is HCAT.

What is company IPO date?

IPO date of Health Catalyst, Inc. is 2019-07-25.

What is company current share price?

Current share price is 6.670 USD.

What is stock market cap today?

The market cap of stock today is 393753445.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1300.